VOR — Vor Biopharma Balance Sheet
0.000.00%
- $274.10m
- $103.64m
Annual balance sheet for Vor Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 48.5 | 207 | 230 | 137 | 91.9 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 49.1 | 214 | 237 | 141 | 96.5 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 21.8 | 22.5 | 57.1 | 50.1 | 41.6 |
| Other Long Term Assets | |||||
| Total Assets | 75.9 | 243 | 299 | 198 | 143 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 10.2 | 10.2 | 13.1 | 15.6 | 18.6 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 27.6 | 26.3 | 48.8 | 47.4 | 46.2 |
| Redeemable Preferred Stock | |||||
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 48.3 | 216 | 251 | 151 | 96.7 |
| Total Liabilities & Shareholders' Equity | 75.9 | 243 | 299 | 198 | 143 |
| Total Common Shares Outstanding |